GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (WBO:LLYC) » Definitions » Common Stock

Eli Lilly and Co (WBO:LLYC) Common Stock : €544 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Eli Lilly and Co Common Stock?

Eli Lilly and Co's quarterly common stock increased from Jun. 2023 (€548 Mil) to Sep. 2023 (€556 Mil) but then declined from Sep. 2023 (€556 Mil) to Dec. 2023 (€544 Mil).

Eli Lilly and Co's annual common stock increased from Dec. 2021 (€528 Mil) to Dec. 2022 (€561 Mil) but then declined from Dec. 2022 (€561 Mil) to Dec. 2023 (€544 Mil).


Eli Lilly and Co Common Stock Historical Data

The historical data trend for Eli Lilly and Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Common Stock Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 538.92 491.72 527.73 560.83 544.33

Eli Lilly and Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 560.83 554.33 547.89 556.20 544.33

Eli Lilly and Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Eli Lilly and Co (WBO:LLYC) Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Eli Lilly and Co (WBO:LLYC) Headlines

No Headlines